Sharing lessons learnt across European cardiovascular research consortia

Drug Discov Today. 2020 Apr;25(4):787-792. doi: 10.1016/j.drudis.2020.01.009. Epub 2020 Jan 22.


Research consortia in Europe often compete with each other for skills, human and technical resources and, eventually, recognition of the scientific impact of their work. In response to the same EU Horizon2020 call, we received funding for our research project proposals to identify and validate novel drug targets for cardiovascular disease treatment. Each consortium followed a unique and independent research strategy. However, as coordinators of these consortia we envisioned we could increase impact, outcomes and efficiency by intensifying our interaction. At an agreed stage during our projects we chose to share our knowledge, vision and ideas. In this paper we present what we learned, in the hope that future consortia will see the benefits of this approach.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomedical Research / organization & administration*
  • Cardiovascular Diseases / drug therapy*
  • Drug Development / methods*
  • Europe
  • Humans
  • Molecular Targeted Therapy